Tagged with research

Taiwan Leveraging Taiwan’s remarkable talent pool in chemistry, some of the country’s fastest-growing companies have been concentrating their efforts on technology platforms that allow them to develop a plethora of potentially game-changing products, rather than focusing all their resources on the risky development of a single, potentially groundbreaking product.   Taiwan…

Mexico The CEO of Accelerium Clinical Research, Ciro Garcia speaks about the trends currently impacting Mexico’s clinical research space, while detailing the company’s ambition to pivot from just one full-service research center to the nation’s leading network of clinical research facilities. Could you please introduce yourself to our international audience as…

Switzerland Markus Arigoni, CEO of Ticino-based micronization specialists Micro-Macinazione, describes the scope of the company’s operations, the enlargement of the firm’s R&D capacities, and emerging trends in the micronization niche. Micro-Macinazione SA was founded back in 1970 and has subsequently developed into one of Europe’s most renowned providers of micronization of…

Mexico Positioning itself as a flexible local CRO with an in-depth knowledge of the Mexican market, iLS Clinical Research CEO, Alejandro Arias, shares his insights on how to be the ideal partner for international expansion. He speaks about the company’s milestones and background, navigating through the challenges of the Mexican CRO…

Taiwan Wayne Wang, director general of Hsinchu Science Park (HSP), the country’s largest and oldest innovation cluster and the first in Taiwan to establish a science park exclusively dedicated to the life sciences industry, documents the potential of HSP as a world-class eco-system for start-ups, local and international mature companies, prestigious…

Mexico With an impressive achievement of growing the novel “flexible solutions” business unit by an astounding 50 percent in his first year of spearheading the region, Ricardo Uribe, Covance Mexico’s Director of Country Operations, shares his insights into the attractiveness of the region for clinical research. He speaks about the impressive…

Switzerland Despite increasing consolidation in the clinical trial industry, there’s enough market share to go around says SOCAR Research CEO Bridget-Anne Kirwan. For SOCAR Research, it’s the company’s strong academic roots in addition to personalized, tailored and innovative services that have helped to make the difference. To begin, could you please…

Mexico Arturo Rodríguez Jacob, CEO at Infinite Clinical Research (ICR) and president of the national association of CROs (ACROM), explains what make Mexico the regional clinical research hub and showcases how ICR is developing clinical studies for allopathic, biotech, medtech, and herbal medicine companies. Only 15 years ago, the Mexican clinical…

Italy Prof. Luca G. Guidotti discusses the esteemed positioning of San Raffaele within the global scientific community, their core mission of translational medicine and the challenges Italy faces today with the development of young scientific talent and the bridging of the public-private gap. Prof. Guidotti, could you begin by describing the…

Italy The division of neuroscience at the San Raffaele Scientific Institute is one of the best worldwide performers in academic research. Division director Professor Gianvito Martino discusses the institute’s unique operative model, national limitations, and the future of the neuroscience field as an investment opportunity. Prof. Martino, to start off, the…

Italy Professor Angelo Corti, Director of the Experimental Oncology division of the SRSI, discusses approaches to oncology research and the institute´s significant contribution to the field in Italy. What is the philosophy of the SRSI’s oncology division towards oncology research? The development of new strategies to improve cancer prevention, detection and…

Italy Dr. Paola Pozzi, the head of the Office of Biotechnology Transfer at the San Raffaele Scientific Institute, discusses the crucial role the OBT occupies as a link between the industry and early-stage research at the institute, as well as her views on the changing culture surrounding the commercialization of research…